November 05th, 2023

On Monday, November 6, a series of companies are gearing up to release their financial results, including: NXP Semiconductors N.V. (Nasdaq: NXPI), a prominent semiconductor manufacturer, will unveil its financial results for the third quarter of 2. Read more

November 05th, 2023

On Thursday, November 9, several companies are poised to unveil their financial reports, including: Sony Group Corporation (NYSE: SONY), a multinational conglomerate, is geared to disclose its second-quarter fiscal 2023 earnings results before the. Read more

November 04th, 2023

On Wednesday, November 8, several notable companies are slated to disclose their financial performance, including: The Walt Disney Company (NYSE: DIS), a leading entertainment conglomerate, will present its fiscal full-year and fourth-quarter 2023. Read more

November 04th, 2023

On Tuesday, November 7, several significant companies are slated to unveil their financial results, including: Gilead Sciences, Inc. (Nasdaq: GILD), a leading biopharmaceutical company, will release its third-quarter 2023 financial results and gui. Read more

November 04th, 2023

On Monday, November 6, several notable companies are set to disclose their financial reports, including: Ryanair Holdings plc (Nasdaq: RYAAY), a leading international airline, is poised to reveal its second-quarter and first-half fiscal 2024 finan. Read more

November 01st, 2023

Roku, Inc. (Nasdaq: ROKU) reported a third-quarter 2023 loss of $(2.33) per share, falling short of the consensus estimate loss of $(2.08) per share. Despite the loss, the company's quarterly revenues reached $912.02 million, surpassing analysts' exp. Read more

November 01st, 2023

In the electric vehicle industry, major players such as Li Auto Inc. (Nasdaq: LI), XPeng Inc. (NYSE: XPEV), and NIO Inc. (NYSE: NIO) have reported their vehicle delivery figures for October 2023. Li Auto achieved a milestone by delivering 40,422 v. Read more

November 01st, 2023

Shares of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) experienced a drastic over 20% decline in after-hours trading following the release of Phase 2 proof-of-concept study results for TNX-601 ER, intended for patients with major depressive dis. Read more

October 31st, 2023

Amgen Inc. (Nasdaq: AMGN), a global biotechnology company, posted third-quarter 2023 earnings per share (EPS) of $4.96, surpassing the consensus EPS estimate of $4.66. The company's quarterly revenues stood at $6.90 billion, slightly below analysts' . Read more

October 30th, 2023

Pulmonx Corporation (Nasdaq: LUNG) reported a narrower loss than expected in the third quarter of 2023, posting a loss of $(0.39) per share, surpassing the consensus estimate loss of $(0.43) per share. The company's quarterly sales stood at $17.67 mi. Read more